Dr.

Jonathan Bohlen

B2
B3
Affiliated Group

Dr.

Jonathan Bohlen

Research Group Leader "mRNA Translation in Human Immunity", Gene Center and Department of Biochemistry, Faculty of Chemistry and Pharmacy

Ludwig-Maximilians-Universität München

Research background

Gene expression is not determined solely at the level of transcription but is critically shaped by the regulation of messenger RNA (mRNA) translation into proteins. Ribosomes, transfer RNAs (tRNAs), and translation initiation and elongation factors coordinate this process, ensuring that genetic information encoded in RNA is accurately and efficiently decoded. How defects in this translational machinery perturb immune cell development and function, and how such disturbances give rise to human disease, remain incompletely understood.

The research of Jonathan Bohlen investigates monogenic disorders that affect components of the mRNA translational apparatus and explores how altered translation control impacts leukocyte biology. His work focuses on translational regulation in T cells, on developmental and functional defects in B cells caused by ribosomopathies, and on monogenic abnormalities in tRNA metabolism and biogenesis that drive autoinflammatory disease in myeloid cells. Using advanced approaches to analyze translational control in primary human leukocytes from healthy individuals and patients, combined with experimental immunology, this research seeks to define how dysregulated RNA translation contributes to immunodeficiency and inflammatory pathologies.

Research fields
Publications

Somatic deficiency of the human E3 ubiquitin ligase CBL in leukocytes impairs B cell but not T cell development and function.

Vatovec, T.; Neehus, AL.; Jackson, KJL.; Avery, DT.; Bagarić, I.; Erazo, L.; Arango-Franco, CA.; Ogishi, M.; Ahmed, SF.; Cederholm, A.; Russell, AJ.; Della Mina, E.; Al-Rifai, D.; Bull, R.; Buetow, L.; Sobrino, S.; Zhang, A.; Wahlster, L.; Michelet, M.; Parvaneh, N.; Peel, J.; Barzaghi, F.; Leardini, D.; Philippot, Q.; Saettini, F.; Dutrieux, J.; de Muylder, B.; Vendemini, F.; Baccelli, F.; Catala, A.; Gambineri, E.; Veltroni, M.; Pandiarajan, V.; Aguilar, Y.; Haerynck, F.; Elliott, M.; Turville, S.; Brillot, F.; Khan, T.; Consonni, F.; Berteloot, L.; Sewell, WA.; Rao, G.; Largeaud, L.; Conti, F.; Roullion, C.; Masson, C.; Pegoraro, F.; Ye, T.; Joubran, S.; Villalpando, E.; Bessot, B.; Seeleuthner, Y.; Le Voyer, T.; Rosain, J.; Li, H.; Janda, Z.; Muratore, E.; Soudée, C.; Delabesse, E.; Goulvestre, C.; Shahrooei, M.; Puel, A.; André, I.; Bole-Feysot, C.; Abel, L.; Erlacher, M.; Béziat, V.; Lagresle-Peyrou, C.; Cheynier, R.; Six, E.; Marr, N.; Pasquet, M.; Alsina, L.; Goodnow, CC.; Landegren, N.; Aiuti, A.; Zhang, P.; Masetti, R.; Huang, DT.; Ma, CS.; Casanova, JL.; Sankaran, VG.; Bustamante, J.; Tangye, SG.; Bohlen, J.

Nat Immunol. · 2026

Show abstract

The E3 ubiquitin ligase Casitas B-lineage lymphoma (CBL) promotes positive selection and antigen responses in mouse T lymphocytes by ubiquitinating ZAP70. Conversely, mouse CBL and CBL-B mutually redundantly regulate SYK ubiquitination and B cell receptor signaling. Here we studied individuals with somatically homozygous CBL loss-of-function variants in leukocytes. Human CBL is largely redundant for the development and function of human T cells. Conversely, B cell development is altered at the immature stage, with a tenfold increase in transitional cells, enhanced survival of autoreactive clones and impaired tolerance manifested by autoantibody production. B cell maturation is intrinsically impaired by reduced apoptosis and dysregulated B cell receptor signaling. CBL deficiency impairs humoral immunity by limiting memory B cell formation and reducing class switching and somatic hypermutation. Consequently, antigen-specific B cell generation and adaptive immune memory are disrupted, predisposing individuals to infection. Human CBL is critical for B cell development and function but redundant for T cell biology.

Autoinflammation in patients with leukocytic CBL loss of heterozygosity is caused by constitutive ERK-mediated monocyte activation.

Bohlen, J.; Bagarić, I.; Vatovec, T.; Ogishi, M.; Ahmed, SF.; Cederholm, A.; Buetow, L.; Sobrino, S.; Le Floc'h, C.; Arango-Franco, CA.; Seabra, L.; Michelet, M.; Barzaghi, F.; Leardini, D.; Saettini, F.; Vendemini, F.; Baccelli, F.; Catala, A.; Gambineri, E.; Veltroni, M.; Aguilar de la Red, Y.; Rice, GI.; Consonni, F.; Berteloot, L.; Largeaud, L.; Conti, F.; Roullion, C.; Masson, C.; Bessot, B.; Seeleuthner, Y.; Le Voyer, T.; Rinchai, D.; Rosain, J.; Neehus, AL.; Erazo-Borrás, L.; Li, H.; Janda, Z.; Cho, EJ.; Muratore, E.; Soudée, C.; Lainé, C.; Delabesse, E.; Goulvestre, C.; Ma, CS.; Puel, A.; Tangye, SG.; André, I.; Bole-Feysot, C.; Abel, L.; Erlacher, M.; Zhang, SY.; Béziat, V.; Lagresle-Peyrou, C.; Six, E.; Pasquet, M.; Alsina, L.; Aiuti, A.; Zhang, P.; Crow, YJ.; Landegren, N.; Masetti, R.; Huang, DT.; Casanova, JL.; Bustamante, J.

J Clin Invest. · 2024

Show abstract

Patients heterozygous for germline CBL loss-of-function (LOF) variants can develop myeloid malignancy, autoinflammation, or both, if some or all of their leukocytes become homozygous for these variants through somatic loss of heterozygosity (LOH) via uniparental isodisomy. We observed an upregulation of the inflammatory gene expression signature in whole blood from these patients, mimicking monogenic inborn errors underlying autoinflammation. Remarkably, these patients had constitutively activated monocytes that secreted 10 to 100 times more inflammatory cytokines than those of healthy individuals and CBL LOF heterozygotes without LOH. CBL-LOH hematopoietic stem and progenitor cells (HSPCs) outgrew the other cells, accounting for the persistence of peripheral monocytes homozygous for the CBL LOF variant. ERK pathway activation was required for the excessive production of cytokines by both resting and stimulated CBL-LOF monocytes, as shown in monocytic cell lines. Finally, we found that about 1 in 10,000 individuals in the UK Biobank were heterozygous for CBL LOF variants and that these carriers were at high risk of hematological and inflammatory conditions.

Human MCTS1-dependent translation of JAK2 is essential for IFN-γ immunity to mycobacteria.

Bohlen, J.; Zhou, Q.; Philippot, Q.; Ogishi, M.; Rinchai, D.; Nieminen, T.; Seyedpour, S.; Parvaneh, N.; Rezaei, N.; Yazdanpanah, N.; Momenilandi, M.; Conil, C.; Neehus, AL.; Schmidt, C.; Arango-Franco, CA.; Voyer, TL.; Khan, T.; Yang, R.; Puchan, J.; Erazo, L.; Roiuk, M.; Vatovec, T.; Janda, Z.; Bagarić, I.; Materna, M.; Gervais, A.; Li, H.; Rosain, J.; Peel, JN.; Seeleuthner, Y.; Han, JE.; L'Honneur, AS.; Moncada-Vélez, M.; Martin-Fernandez, M.; Horesh, ME.; Kochetkov, T.; Schmidt, M.; AlShehri, MA.; Salo, E.; Saxen, H.; ElGhazali, G.; Yatim, A.; Soudée, C.; Sallusto, F.; Ensser, A.; Marr, N.; Zhang, P.; Bogunovic, D.; Cobat, A.; Shahrooei, M.; Béziat, V.; Abel, L.; Wang, X.; Boisson-Dupuis, S.; Teleman, AA.; Bustamante, J.; Zhang, Q.; Casanova, JL.

Cell. · 2023

Show abstract

Human inherited disorders of interferon-gamma (IFN-γ) immunity underlie severe mycobacterial diseases. We report X-linked recessive MCTS1 deficiency in men with mycobacterial disease from kindreds of different ancestries (from China, Finland, Iran, and Saudi Arabia). Complete deficiency of this translation re-initiation factor impairs the translation of a subset of proteins, including the kinase JAK2 in all cell types tested, including T lymphocytes and phagocytes. JAK2 expression is sufficiently low to impair cellular responses to interleukin-23 (IL-23) and partially IL-12, but not other JAK2-dependent cytokines. Defective responses to IL-23 preferentially impair the production of IFN-γ by innate-like adaptive mucosal-associated invariant T cells (MAIT) and γδ T lymphocytes upon mycobacterial challenge. Surprisingly, the lack of MCTS1-dependent translation re-initiation and ribosome recycling seems to be otherwise physiologically redundant in these patients. These findings suggest that X-linked recessive human MCTS1 deficiency underlies isolated mycobacterial disease by impairing JAK2 translation in innate-like adaptive T lymphocytes, thereby impairing the IL-23-dependent induction of IFN-γ.

DENR promotes translation reinitiation via ribosome recycling to drive expression of oncogenes including ATF4.

Bohlen, J.; Harbrecht, L.; Blanco, S.; Clemm von Hohenberg, K.; Fenzl, K.; Kramer, G.; Bukau, B.; Teleman, AA.

Nat Commun. · 2020

Show abstract

Translation efficiency varies considerably between different mRNAs, thereby impacting protein expression. Translation of the stress response master-regulator ATF4 increases upon stress, but the molecular mechanisms are not well understood. We discover here that translation factors DENR, MCTS1 and eIF2D are required to induce ATF4 translation upon stress by promoting translation reinitiation in the ATF4 5'UTR. We find DENR and MCTS1 are only needed for reinitiation after upstream Open Reading Frames (uORFs) containing certain penultimate codons, perhaps because DENR•MCTS1 are needed to evict only certain tRNAs from post-termination 40S ribosomes. This provides a model for how DENR and MCTS1 promote translation reinitiation. Cancer cells, which are exposed to many stresses, require ATF4 for survival and proliferation. We find a strong correlation between DENR•MCTS1 expression and ATF4 activity across cancers. Furthermore, additional oncogenes including a-Raf, c-Raf and Cdk4 have long uORFs and are translated in a DENR•MCTS1 dependent manner.

Selective 40S Footprinting Reveals Cap-Tethered Ribosome Scanning in Human Cells.

Bohlen, J.; Fenzl, K.; Kramer, G.; Bukau, B.; Teleman, AA.

Mol Cell. · 2020

Show abstract

Translation regulation occurs largely during the initiation phase. Here, we develop selective 40S footprinting to visualize initiating 40S ribosomes on endogenous mRNAs in vivo. This reveals the positions on mRNAs where initiation factors join the ribosome to act and where they leave. We discover that in most human cells, most scanning ribosomes remain attached to the 5' cap. Consequently, only one ribosome scans a 5' UTR at a time, and 5' UTR length affects translation efficiency. We discover that eukaryotic initiation factor 3B (eIF3B,) eIF4G1, and eIF4E remain bound to 80S ribosomes as they begin translating, with a decay half-length of ∼12 codons. Hence, ribosomes retain these initiation factors while translating short upstream open reading frames (uORFs), providing an explanation for how ribosomes can reinitiate translation after uORFs in humans. This method will be of use for studying translation initiation mechanisms in vivo.